Piclib

Composition:

Palbociclib 75mg / 100mg / 125mg

Description:

Piclib is an advanced oncology therapy designed to slow the progression of HR-positive, HER2-negative metastatic breast cancer. It contains palbociclib, a CDK4/6 inhibitor that targets proteins responsible for cell division, effectively halting the proliferation of cancer cells. Used in combination with hormonal therapies, Piclib helps extend progression-free survival and provides a targeted treatment approach with manageable side effects.

It has become a critical component in breast cancer care, especially for patients seeking a well-tolerated oral option that works at the cellular level to delay disease advancement.


Usage Instructions

Take Piclib once daily with food at the same time each day. Swallow the capsule whole without crushing or chewing.

Benefits and Use

Piclib helps slow the growth of cancer cells, prolonging progression-free survival in patients with advanced or metastatic breast cancer.

Safety Information

Monitor complete blood counts regularly. Avoid grapefruit or certain interacting drugs. Use effective contraception during treatment.
Write to Us

Share your experience with our medical product. Write a review!

Blog

24 Dec 2025

Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness

(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)

Read More

16 Dec 2025

Top 7 Everyday Foods That Trigger Acidity - And How Jeerafast Helps You Enjoy Meals Without the Burn

(A complete Indian-friendly guide for digestion, bloating, acidity, and natural relief)

Read More

17 Nov 2025

Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma

When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.

Read More

17 Nov 2025

The Role of Lifestyle Modifications in Chronic Disease Prevention

Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”

Read More